Skip to main content
padlock icon - secure page this page is secure

Development and In Vitro Characterizations of Bifendate Nanosuspensions

Buy Article:

$106.73 + tax (Refund Policy)

It is reported that nano-sizing is one of the promising methods for improving the dissolution rate and oral bioavailability of poorly water-soluble drugs. In this study, bifendate (DDB) suspensions have been successfully produced by employing two different techniques, the precipitation-ultrasonication method and the precipitation-combined microfluidization method. According to the preliminary test, in the precipitation-ultrasonication process, the concentrations of polyvinylpyrrolidone K30 (PVPK30) and lecithin in the anti-solvent, the concentration of DDB in the organic phase and the precipitation temperature were optimized at 0.05%, 0.2%, 40 mg/ml and 0–3 °C, respectively. In the microfluidization process, two important parameters, the number of cycles and the pressure were investigated systematically and 10 cycles at 23,300 psi of homogenization pressure was found to be the most efficient method. Comparing the two kinds of suspensions by TEM and particle size analysis, a small and uniform size with narrow distribution was achieved by the precipitation-combined microfluidization process. Both formulations before and after particle size reduction were characterized by differential scanning calorimetry (DSC) and X-ray diffraction (XRD). The DSC and XRD testified that there was no crystalline state changed in the size reduction process. In the in vitro dissolution test, an enhanced dissolution property was shown due to the increased surface area. Besides, lyophilization of DDB nanosuspensions was an effective measure to stabilize the systems for long time.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: DDB; DIFFERENTIAL SCANNING CALORIMETRY; IN VITRO RELEASE; PRECIPITATION-COMBINED MICROFLUIDIZATION; X-RAY DIFFRACTION

Document Type: Research Article

Publication date: October 1, 2011

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more